AquaBounty Technologies, a Waltham company that has created a genetically engineered Atlantic salmon, is treading water while it waits for the Food and Drug Administration to decide whether it can sell its fast-growing fish to the public.
The already lengthy federal approval process has grown longer and more complicated in the face of strong opposition to the AquAdvantage salmon, the nation’s first genetically engineered food fish, by environmental groups, consumer advocates, and some lawmakers.
But these efforts are shortsighted, said the company’s president and chief executive, Ronald L. Stotish.
“If anti-[genetically engineered] food activists succeed, the unintended consequence is that we will still one day be eating [genetically engineered] animal food – it will be produced elsewhere,’’ he said in a statement.
Read the complete story from The Boston Globe.